On Monday, stock markets in Europe are clearly gaining value, which is related to information about the extension of negotiations on US customs changes. On the other hand, the economic calendar does not contain too many data releases, although in this case, attention will be focused on announcements regarding tariffs. On the cash market, the German DAX is currently up 0.75%, the French CAC40 is up 0.3%, and the British FTSE100 is up 0.05%.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appCurrently observed volatility in the broader European market. Source: xStation
The German DE40 index is gaining 0.92% during today's session and remains above the support zone set by the 50-day exponential moving average (blue curve on the chart). As long as the D40 remains above this zone, the overall upward trend remains stable (as determined by the exponential moving averages). The 14-day RSI is returning to around 53 points (neutral values). Source: xStation
Market news
Commerzbank AG (CBK.DE) plans to sell a significant portion of its corporate loan portfolio risk, according to people familiar with the matter, as the German lender seeks to free up capital to fend off a potential takeover bid from UniCredit SpA (UCG.IT). Commerzbank shares are up 1.6% today following the news.
Energy stocks in Europe fell on weaker-than-expected results from Shell Plc (SHELL.NL) and a decline in oil prices.
The energy giant reported weaker trading results for Q2 and weaker-than-expected profits in its downstream business. Despite higher refining margins of $8.9/bbl (up from $6.2) and chemical margins of $166/tonne (up from $126), Shell expects adjusted earnings in this segment to be below break-even. Furthermore, Shell forecasts a net result of between a $400 million loss and a $200 million profit, compared to a consensus estimate of a $27 million loss. Trading activity is expected to be lower than in the first quarter. The company's shares are down 2.55% today.
Siemens Healthineers (SHL.DE) shares are down 2.2% today. The reason is China's decision to impose import restrictions on medical devices from the European Union, which negatively affects the company's sales prospects in this key market.
Capgemini (CAP.FR) shares are down 2.5% today. The decline is due to the announcement of the acquisition of WNS for $76.50 per share, which involves a cash expenditure of $3.3 billion and raises investor concerns about the potential risks and short-term costs of integrating the acquisition
Source: xStation
Other news from individual DAX companies. Source: Bloomberg Financial LP
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
